▶ 調査レポート

経皮ドラッグデリバリーパッチのグローバル市場 2021年:企業別、地域別、種類・用途別

• 英文タイトル:Global Transdermal Drug Delivery Patches Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。経皮ドラッグデリバリーパッチのグローバル市場 2021年:企業別、地域別、種類・用途別 / Global Transdermal Drug Delivery Patches Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR-203B16358資料のイメージです。• レポートコード:GIR-203B16358
• 出版社/出版日:GlobalInfoResearch / 2021年12月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、105ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥522,000 (USD3,480)▷ お問い合わせ
  Multi User¥783,000 (USD5,220)▷ お問い合わせ
  Corporate User¥1,044,000 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
経皮ドラッグデリバリーパッチ市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の経皮ドラッグデリバリーパッチの市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx%の変化があります。世界の経皮ドラッグデリバリーパッチの市場規模は次の5年間でxxx%のCAGRで成長すると予想されます。

経皮ドラッグデリバリーパッチ市場は種類と用途によって区分されます。2016年~2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・サリチル酸メチルベースパッチ、リバスチグミン経皮パッチ、フェンタニル経皮パッチ、リドカインパッチ、ジクロフェナクパッチ、ニコチン経皮パッチ、その他

用途別セグメントは次のように区分されます。
・Rxチャネル、OTCチャネル

世界の経皮ドラッグデリバリーパッチ市場の主要な市場プレーヤーは以下のとおりです。
・Hisamitsu Pharmaceutical、Johnson & Johnson、Novartis、UCB Pharma、Mylan、Teva Pharmaceutical、Nitto Denko、Grünenthal、IBSA Group、GSK、Luye Pharma Group、Pfizer、Chattem、Dr Reddy’s Laboratories、Bayer、Mundipharma、Endo International、Beijing Tide Pharmaceutical

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計14章あります。
・第1章では、経皮ドラッグデリバリーパッチ製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な経皮ドラッグデリバリーパッチメーカーの企業概要、2019年~2021年までの経皮ドラッグデリバリーパッチの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な経皮ドラッグデリバリーパッチメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2016年~2026年までの地域別経皮ドラッグデリバリーパッチの販売量、売上、成長性を示しています。
・第5、6章では、2016年~2026年までの経皮ドラッグデリバリーパッチの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2016年~2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年~2026年までの主要地域での経皮ドラッグデリバリーパッチ市場予測を収録しています。
・第12、13、14章では、経皮ドラッグデリバリーパッチの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Hisamitsu Pharmaceutical、Johnson & Johnson、Novartis、UCB Pharma、Mylan、Teva Pharmaceutical、Nitto Denko、Grünenthal、IBSA Group、GSK、Luye Pharma Group、Pfizer、Chattem、Dr Reddy’s Laboratories、Bayer、Mundipharma、Endo International、Beijing Tide Pharmaceutical
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:サリチル酸メチルベースパッチ、リバスチグミン経皮パッチ、フェンタニル経皮パッチ、リドカインパッチ、ジクロフェナクパッチ、ニコチン経皮パッチ、その他
・用途別分析2016年-2026年:Rxチャネル、OTCチャネル
・経皮ドラッグデリバリーパッチの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・経皮ドラッグデリバリーパッチのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・経皮ドラッグデリバリーパッチのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・経皮ドラッグデリバリーパッチの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・経皮ドラッグデリバリーパッチの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Transdermal Drug Delivery Patches market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Transdermal Drug Delivery Patches size is estimated to be million in 2021 from USD million in 2020, with a change of % between 2020 and 2021. The global Transdermal Drug Delivery Patches market size is expected to grow at a CAGR of % for the next five years.

Market segmentation
Transdermal Drug Delivery Patches market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others

Market segment by Application can be divided into
Rx Channel
OTC Channel

The key market players for global Transdermal Drug Delivery Patches market are listed below:
Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
Grünenthal
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Dr Reddy’s Laboratories
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Transdermal Drug Delivery Patches product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Transdermal Drug Delivery Patches, with price, sales, revenue and global market share of Transdermal Drug Delivery Patches from 2019 to 2021.
Chapter 3, the Transdermal Drug Delivery Patches competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Transdermal Drug Delivery Patches breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Transdermal Drug Delivery Patches market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Transdermal Drug Delivery Patches sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Transdermal Drug Delivery Patches Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Transdermal Drug Delivery Patches Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Methyl Salicylate-based Patch
1.2.3 Rivastigmine Transdermal Patch
1.2.4 Fentanyl Transdermal Patch
1.2.5 Lidocaine Patch
1.2.6 Diclofenac Patch
1.2.7 Nicotine Transdermal Patch
1.2.8 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Transdermal Drug Delivery Patches Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Rx Channel
1.3.3 OTC Channel
1.4 Global Transdermal Drug Delivery Patches Market Size & Forecast
1.4.1 Global Transdermal Drug Delivery Patches Sales in Value (2016-2026))
1.4.2 Global Transdermal Drug Delivery Patches Sales in Volume (2016-2026)
1.4.3 Global Transdermal Drug Delivery Patches Price by Type (2016-2026) & (US$/Unit)
1.5 Global Transdermal Drug Delivery Patches Production Capacity Analysis
1.5.1 Global Transdermal Drug Delivery Patches Total Production Capacity (2016-2026)
1.5.2 Global Transdermal Drug Delivery Patches Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Transdermal Drug Delivery Patches Market Drivers
1.6.2 Transdermal Drug Delivery Patches Market Restraints
1.6.3 Transdermal Drug Delivery Patches Trends Analysis
2 Manufacturers Profiles
2.1 Hisamitsu Pharmaceutical
2.1.1 Hisamitsu Pharmaceutical Details
2.1.2 Hisamitsu Pharmaceutical Major Business
2.1.3 Hisamitsu Pharmaceutical Transdermal Drug Delivery Patches Product and Services
2.1.4 Hisamitsu Pharmaceutical Transdermal Drug Delivery Patches Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Transdermal Drug Delivery Patches Product and Services
2.2.4 Johnson & Johnson Transdermal Drug Delivery Patches Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Transdermal Drug Delivery Patches Product and Services
2.3.4 Novartis Transdermal Drug Delivery Patches Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 UCB Pharma
2.4.1 UCB Pharma Details
2.4.2 UCB Pharma Major Business
2.4.3 UCB Pharma Transdermal Drug Delivery Patches Product and Services
2.4.4 UCB Pharma Transdermal Drug Delivery Patches Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Mylan
2.5.1 Mylan Details
2.5.2 Mylan Major Business
2.5.3 Mylan Transdermal Drug Delivery Patches Product and Services
2.5.4 Mylan Transdermal Drug Delivery Patches Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Teva Pharmaceutical
2.6.1 Teva Pharmaceutical Details
2.6.2 Teva Pharmaceutical Major Business
2.6.3 Teva Pharmaceutical Transdermal Drug Delivery Patches Product and Services
2.6.4 Teva Pharmaceutical Transdermal Drug Delivery Patches Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Nitto Denko
2.7.1 Nitto Denko Details
2.7.2 Nitto Denko Major Business
2.7.3 Nitto Denko Transdermal Drug Delivery Patches Product and Services
2.7.4 Nitto Denko Transdermal Drug Delivery Patches Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Grünenthal
2.8.1 Grünenthal Details
2.8.2 Grünenthal Major Business
2.8.3 Grünenthal Transdermal Drug Delivery Patches Product and Services
2.8.4 Grünenthal Transdermal Drug Delivery Patches Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 IBSA Group
2.9.1 IBSA Group Details
2.9.2 IBSA Group Major Business
2.9.3 IBSA Group Transdermal Drug Delivery Patches Product and Services
2.9.4 IBSA Group Transdermal Drug Delivery Patches Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 GSK
2.10.1 GSK Details
2.10.2 GSK Major Business
2.10.3 GSK Transdermal Drug Delivery Patches Product and Services
2.10.4 GSK Transdermal Drug Delivery Patches Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Luye Pharma Group
2.11.1 Luye Pharma Group Details
2.11.2 Luye Pharma Group Major Business
2.11.3 Luye Pharma Group Transdermal Drug Delivery Patches Product and Services
2.11.4 Luye Pharma Group Transdermal Drug Delivery Patches Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Pfizer
2.12.1 Pfizer Details
2.12.2 Pfizer Major Business
2.12.3 Pfizer Transdermal Drug Delivery Patches Product and Services
2.12.4 Pfizer Transdermal Drug Delivery Patches Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Chattem
2.13.1 Chattem Details
2.13.2 Chattem Major Business
2.13.3 Chattem Transdermal Drug Delivery Patches Product and Services
2.13.4 Chattem Transdermal Drug Delivery Patches Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Dr Reddy’s Laboratories
2.14.1 Dr Reddy’s Laboratories Details
2.14.2 Dr Reddy’s Laboratories Major Business
2.14.3 Dr Reddy’s Laboratories Transdermal Drug Delivery Patches Product and Services
2.14.4 Dr Reddy’s Laboratories Transdermal Drug Delivery Patches Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Bayer
2.15.1 Bayer Details
2.15.2 Bayer Major Business
2.15.3 Bayer Transdermal Drug Delivery Patches Product and Services
2.15.4 Bayer Transdermal Drug Delivery Patches Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Mundipharma
2.16.1 Mundipharma Details
2.16.2 Mundipharma Major Business
2.16.3 Mundipharma Transdermal Drug Delivery Patches Product and Services
2.16.4 Mundipharma Transdermal Drug Delivery Patches Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 Endo International
2.17.1 Endo International Details
2.17.2 Endo International Major Business
2.17.3 Endo International Transdermal Drug Delivery Patches Product and Services
2.17.4 Endo International Transdermal Drug Delivery Patches Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 Beijing Tide Pharmaceutical
2.18.1 Beijing Tide Pharmaceutical Details
2.18.2 Beijing Tide Pharmaceutical Major Business
2.18.3 Beijing Tide Pharmaceutical Transdermal Drug Delivery Patches Product and Services
2.18.4 Beijing Tide Pharmaceutical Transdermal Drug Delivery Patches Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Transdermal Drug Delivery Patches Sales by Manufacturer
3.1 Global Transdermal Drug Delivery Patches Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Transdermal Drug Delivery Patches Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Transdermal Drug Delivery Patches
3.4 Market Concentration Rate
3.4.1 Top 3 Transdermal Drug Delivery Patches Manufacturer Market Share
3.4.2 Top 6 Transdermal Drug Delivery Patches Manufacturer Market Share
3.5 Global Transdermal Drug Delivery Patches Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Transdermal Drug Delivery Patches Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Transdermal Drug Delivery Patches Market Size by Region
4.1.1 Global Transdermal Drug Delivery Patches Sales in Volume by Region (2016-2026)
4.1.2 Global Transdermal Drug Delivery Patches Revenue by Region (2016-2026)
4.2 North America Transdermal Drug Delivery Patches Revenue (2016-2026)
4.3 Europe Transdermal Drug Delivery Patches Revenue (2016-2026)
4.4 Asia-Pacific Transdermal Drug Delivery Patches Revenue (2016-2026)
4.5 South America Transdermal Drug Delivery Patches Revenue (2016-2026)
4.6 Middle East and Africa Transdermal Drug Delivery Patches Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Transdermal Drug Delivery Patches Sales in Volume by Type (2016-2026)
5.2 Global Transdermal Drug Delivery Patches Revenue by Type (2016-2026)
5.3 Global Transdermal Drug Delivery Patches Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Transdermal Drug Delivery Patches Sales in Volume by Application (2016-2026)
6.2 Global Transdermal Drug Delivery Patches Revenue by Application (2016-2026)
6.3 Global Transdermal Drug Delivery Patches Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Transdermal Drug Delivery Patches Sales by Type (2016-2026)
7.2 North America Transdermal Drug Delivery Patches Sales by Application (2016-2026)
7.3 North America Transdermal Drug Delivery Patches Market Size by Country
7.3.1 North America Transdermal Drug Delivery Patches Sales in Volume by Country (2016-2026)
7.3.2 North America Transdermal Drug Delivery Patches Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Transdermal Drug Delivery Patches Sales by Type (2016-2026)
8.2 Europe Transdermal Drug Delivery Patches Sales by Application (2016-2026)
8.3 Europe Transdermal Drug Delivery Patches Market Size by Country
8.3.1 Europe Transdermal Drug Delivery Patches Sales in Volume by Country (2016-2026)
8.3.2 Europe Transdermal Drug Delivery Patches Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Transdermal Drug Delivery Patches Sales by Type (2016-2026)
9.2 Asia-Pacific Transdermal Drug Delivery Patches Sales by Application (2016-2026)
9.3 Asia-Pacific Transdermal Drug Delivery Patches Market Size by Region
9.3.1 Asia-Pacific Transdermal Drug Delivery Patches Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Transdermal Drug Delivery Patches Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Transdermal Drug Delivery Patches Sales by Type (2016-2026)
10.2 South America Transdermal Drug Delivery Patches Sales by Application (2016-2026)
10.3 South America Transdermal Drug Delivery Patches Market Size by Country
10.3.1 South America Transdermal Drug Delivery Patches Sales in Volume by Country (2016-2026)
10.3.2 South America Transdermal Drug Delivery Patches Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Transdermal Drug Delivery Patches Sales by Type (2016-2026)
11.2 Middle East & Africa Transdermal Drug Delivery Patches Sales by Application (2016-2026)
11.3 Middle East & Africa Transdermal Drug Delivery Patches Market Size by Country
11.3.1 Middle East & Africa Transdermal Drug Delivery Patches Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Transdermal Drug Delivery Patches Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Transdermal Drug Delivery Patches Typical Distributors
12.3 Transdermal Drug Delivery Patches Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Transdermal Drug Delivery Patches Revenue by Type, (USD Million), 2021-2026
Table 2. Global Transdermal Drug Delivery Patches Revenue by Application, (USD Million), 2021-2026
Table 3. Hisamitsu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Hisamitsu Pharmaceutical Major Business
Table 5. Hisamitsu Pharmaceutical Transdermal Drug Delivery Patches Product and Services
Table 6. Hisamitsu Pharmaceutical Transdermal Drug Delivery Patches Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 8. Johnson & Johnson Major Business
Table 9. Johnson & Johnson Transdermal Drug Delivery Patches Product and Services
Table 10. Johnson & Johnson Transdermal Drug Delivery Patches Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Novartis Basic Information, Manufacturing Base and Competitors
Table 12. Novartis Major Business
Table 13. Novartis Transdermal Drug Delivery Patches Product and Services
Table 14. Novartis Transdermal Drug Delivery Patches Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. UCB Pharma Basic Information, Manufacturing Base and Competitors
Table 16. UCB Pharma Major Business
Table 17. UCB Pharma Transdermal Drug Delivery Patches Product and Services
Table 18. UCB Pharma Transdermal Drug Delivery Patches Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Mylan Basic Information, Manufacturing Base and Competitors
Table 20. Mylan Major Business
Table 21. Mylan Transdermal Drug Delivery Patches Product and Services
Table 22. Mylan Transdermal Drug Delivery Patches Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Teva Pharmaceutical Major Business
Table 25. Teva Pharmaceutical Transdermal Drug Delivery Patches Product and Services
Table 26. Teva Pharmaceutical Transdermal Drug Delivery Patches Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Nitto Denko Basic Information, Manufacturing Base and Competitors
Table 28. Nitto Denko Major Business
Table 29. Nitto Denko Transdermal Drug Delivery Patches Product and Services
Table 30. Nitto Denko Transdermal Drug Delivery Patches Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Grünenthal Basic Information, Manufacturing Base and Competitors
Table 32. Grünenthal Major Business
Table 33. Grünenthal Transdermal Drug Delivery Patches Product and Services
Table 34. Grünenthal Transdermal Drug Delivery Patches Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. IBSA Group Basic Information, Manufacturing Base and Competitors
Table 36. IBSA Group Major Business
Table 37. IBSA Group Transdermal Drug Delivery Patches Product and Services
Table 38. IBSA Group Transdermal Drug Delivery Patches Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. GSK Basic Information, Manufacturing Base and Competitors
Table 40. GSK Major Business
Table 41. GSK Transdermal Drug Delivery Patches Product and Services
Table 42. GSK Transdermal Drug Delivery Patches Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Luye Pharma Group Basic Information, Manufacturing Base and Competitors
Table 44. Luye Pharma Group Major Business
Table 45. Luye Pharma Group Transdermal Drug Delivery Patches Product and Services
Table 46. Luye Pharma Group Transdermal Drug Delivery Patches Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Pfizer Basic Information, Manufacturing Base and Competitors
Table 48. Pfizer Major Business
Table 49. Pfizer Transdermal Drug Delivery Patches Product and Services
Table 50. Pfizer Transdermal Drug Delivery Patches Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Chattem Basic Information, Manufacturing Base and Competitors
Table 52. Chattem Major Business
Table 53. Chattem Transdermal Drug Delivery Patches Product and Services
Table 54. Chattem Transdermal Drug Delivery Patches Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Dr Reddy’s Laboratories Basic Information, Manufacturing Base and Competitors
Table 56. Dr Reddy’s Laboratories Major Business
Table 57. Dr Reddy’s Laboratories Transdermal Drug Delivery Patches Product and Services
Table 58. Dr Reddy’s Laboratories Transdermal Drug Delivery Patches Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Bayer Basic Information, Manufacturing Base and Competitors
Table 60. Bayer Major Business
Table 61. Bayer Transdermal Drug Delivery Patches Product and Services
Table 62. Bayer Transdermal Drug Delivery Patches Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Mundipharma Basic Information, Manufacturing Base and Competitors
Table 64. Mundipharma Major Business
Table 65. Mundipharma Transdermal Drug Delivery Patches Product and Services
Table 66. Mundipharma Transdermal Drug Delivery Patches Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Endo International Basic Information, Manufacturing Base and Competitors
Table 68. Endo International Major Business
Table 69. Endo International Transdermal Drug Delivery Patches Product and Services
Table 70. Endo International Transdermal Drug Delivery Patches Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Beijing Tide Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 72. Beijing Tide Pharmaceutical Major Business
Table 73. Beijing Tide Pharmaceutical Transdermal Drug Delivery Patches Product and Services
Table 74. Beijing Tide Pharmaceutical Transdermal Drug Delivery Patches Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Global Transdermal Drug Delivery Patches Sales by Manufacturer (2019-2021e) & (K Units)
Table 76. Global Transdermal Drug Delivery Patches Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 77. Market Position of Manufacturers in Transdermal Drug Delivery Patches, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 78. Global Transdermal Drug Delivery Patches Production Capacity by Company, (K Units): 2020 VS 2021
Table 79. Head Office and Transdermal Drug Delivery Patches Production Site of Key Manufacturer
Table 80. Transdermal Drug Delivery Patches New Entrant and Capacity Expansion Plans
Table 81. Transdermal Drug Delivery Patches Mergers & Acquisitions in the Past Five Years
Table 82. Global Transdermal Drug Delivery Patches Sales by Region (2016-2021e) & (K Units)
Table 83. Global Transdermal Drug Delivery Patches Sales by Region (2021-2026) & (K Units)
Table 84. Global Transdermal Drug Delivery Patches Revenue by Region (2016-2021e) & (USD Million)
Table 85. Global Transdermal Drug Delivery Patches Revenue by Region (2021-2026) & (USD Million)
Table 86. Global Transdermal Drug Delivery Patches Sales by Type (2016-2021e) & (K Units)
Table 87. Global Transdermal Drug Delivery Patches Sales by Type (2021-2026) & (K Units)
Table 88. Global Transdermal Drug Delivery Patches Revenue by Type (2016-2021e) & (USD Million)
Table 89. Global Transdermal Drug Delivery Patches Revenue by Type (2021-2026) & (USD Million)
Table 90. Global Transdermal Drug Delivery Patches Price by Type (2016-2021e) & (US$/Unit)
Table 91. Global Transdermal Drug Delivery Patches Price by Type (2021-2026) & (US$/Unit)
Table 92. Global Transdermal Drug Delivery Patches Sales by Application (2016-2021e) & (K Units)
Table 93. Global Transdermal Drug Delivery Patches Sales by Application (2021-2026) & (K Units)
Table 94. Global Transdermal Drug Delivery Patches Revenue by Application (2016-2021e) & (USD Million)
Table 95. Global Transdermal Drug Delivery Patches Revenue by Application (2021-2026) & (USD Million)
Table 96. Global Transdermal Drug Delivery Patches Price by Application (2016-2021e) & (US$/Unit)
Table 97. Global Transdermal Drug Delivery Patches Price by Application (2021-2026) & (US$/Unit)
Table 98. North America Transdermal Drug Delivery Patches Sales by Country (2016-2021e) & (K Units)
Table 99. North America Transdermal Drug Delivery Patches Sales by Country (2021-2026) & (K Units)
Table 100. North America Transdermal Drug Delivery Patches Revenue by Country (2016-2021e) & (USD Million)
Table 101. North America Transdermal Drug Delivery Patches Revenue by Country (2021-2026) & (USD Million)
Table 102. North America Transdermal Drug Delivery Patches Sales by Type (2016-2021e) & (K Units)
Table 103. North America Transdermal Drug Delivery Patches Sales by Type (2021-2026) & (K Units)
Table 104. North America Transdermal Drug Delivery Patches Sales by Application (2016-2021e) & (K Units)
Table 105. North America Transdermal Drug Delivery Patches Sales by Application (2021-2026) & (K Units)
Table 106. Europe Transdermal Drug Delivery Patches Sales by Country (2016-2021e) & (K Units)
Table 107. Europe Transdermal Drug Delivery Patches Sales by Country (2021-2026) & (K Units)
Table 108. Europe Transdermal Drug Delivery Patches Revenue by Country (2016-2021e) & (USD Million)
Table 109. Europe Transdermal Drug Delivery Patches Revenue by Country (2021-2026) & (USD Million)
Table 110. Europe Transdermal Drug Delivery Patches Sales by Type (2016-2021e) & (K Units)
Table 111. Europe Transdermal Drug Delivery Patches Sales by Type (2021-2026) & (K Units)
Table 112. Europe Transdermal Drug Delivery Patches Sales by Application (2016-2021e) & (K Units)
Table 113. Europe Transdermal Drug Delivery Patches Sales by Application (2021-2026) & (K Units)
Table 114. Asia-Pacific Transdermal Drug Delivery Patches Sales by Region (2016-2021e) & (K Units)
Table 115. Asia-Pacific Transdermal Drug Delivery Patches Sales by Region (2021-2026) & (K Units)
Table 116. Asia-Pacific Transdermal Drug Delivery Patches Revenue by Region (2016-2021e) & (USD Million)
Table 117. Asia-Pacific Transdermal Drug Delivery Patches Revenue by Region (2021-2026) & (USD Million)
Table 118. Asia-Pacific Transdermal Drug Delivery Patches Sales by Type (2016-2021e) & (K Units)
Table 119. Asia-Pacific Transdermal Drug Delivery Patches Sales by Type (2021-2026) & (K Units)
Table 120. Asia-Pacific Transdermal Drug Delivery Patches Sales by Application (2016-2021e) & (K Units)
Table 121. Asia-Pacific Transdermal Drug Delivery Patches Sales by Application (2021-2026) & (K Units)
Table 122. South America Transdermal Drug Delivery Patches Sales by Country (2016-2021e) & (K Units)
Table 123. South America Transdermal Drug Delivery Patches Sales by Country (2021-2026) & (K Units)
Table 124. South America Transdermal Drug Delivery Patches Revenue by Country (2016-2021e) & (USD Million)
Table 125. South America Transdermal Drug Delivery Patches Revenue by Country (2021-2026) & (USD Million)
Table 126. South America Transdermal Drug Delivery Patches Sales by Type (2016-2021e) & (K Units)
Table 127. South America Transdermal Drug Delivery Patches Sales by Type (2021-2026) & (K Units)
Table 128. South America Transdermal Drug Delivery Patches Sales by Application (2016-2021e) & (K Units)
Table 129. South America Transdermal Drug Delivery Patches Sales by Application (2021-2026) & (K Units)
Table 130. Middle East & Africa Transdermal Drug Delivery Patches Sales by Country (2016-2021e) & (K Units)
Table 131. Middle East & Africa Transdermal Drug Delivery Patches Sales by Country (2021-2026) & (K Units)
Table 132. Middle East & Africa Transdermal Drug Delivery Patches Revenue by Country (2016-2021e) & (USD Million)
Table 133. Middle East & Africa Transdermal Drug Delivery Patches Revenue by Country (2021-2026) & (USD Million)
Table 134. Middle East & Africa Transdermal Drug Delivery Patches Sales by Type (2016-2021e) & (K Units)
Table 135. Middle East & Africa Transdermal Drug Delivery Patches Sales by Type (2021-2026) & (K Units)
Table 136. Middle East & Africa Transdermal Drug Delivery Patches Sales by Application (2016-2021e) & (K Units)
Table 137. Middle East & Africa Transdermal Drug Delivery Patches Sales by Application (2021-2026) & (K Units)
Table 138. Direct Channel Pros & Cons
Table 139. Indirect Channel Pros & Cons
Table 140. Transdermal Drug Delivery Patches Typical Distributors
Table 141. Transdermal Drug Delivery Patches Typical Customers
List of Figures
Figure 1. Transdermal Drug Delivery Patches Picture
Figure 2. Global Transdermal Drug Delivery Patches Sales Market Share by Type in 2020
Figure 3. Methyl Salicylate-based Patch
Figure 4. Rivastigmine Transdermal Patch
Figure 5. Fentanyl Transdermal Patch
Figure 6. Lidocaine Patch
Figure 7. Diclofenac Patch
Figure 8. Nicotine Transdermal Patch
Figure 9. Others
Figure 10. Global Transdermal Drug Delivery Patches Sales Market Share by Application in 2020
Figure 11. Rx Channel
Figure 12. OTC Channel
Figure 13. Global Transdermal Drug Delivery Patches Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 14. Global Transdermal Drug Delivery Patches Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. Global Transdermal Drug Delivery Patches Sales (2016-2026) & (K Units)
Figure 16. Global Transdermal Drug Delivery Patches Price by Type (2016-2026) & (US$/Unit)
Figure 17. Global Transdermal Drug Delivery Patches Production Capacity (2016-2026) & (K Units)
Figure 18. Global Transdermal Drug Delivery Patches Production Capacity by Geographic Region: 2020 VS 2021
Figure 19. Transdermal Drug Delivery Patches Market Drivers
Figure 20. Transdermal Drug Delivery Patches Market Restraints
Figure 21. Transdermal Drug Delivery Patches Market Trends
Figure 22. Global Transdermal Drug Delivery Patches Sales Market Share by Manufacturer in 2020
Figure 23. Global Transdermal Drug Delivery Patches Revenue Market Share by Manufacturer in 2020
Figure 24. Transdermal Drug Delivery Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 25. Top 3 Transdermal Drug Delivery Patches Manufacturer (Revenue) Market Share in 2020
Figure 26. Top 6 Transdermal Drug Delivery Patches Manufacturer (Revenue) Market Share in 2020
Figure 27. Global Transdermal Drug Delivery Patches Sales Market Share by Region (2016-2026)
Figure 28. Global Transdermal Drug Delivery Patches Revenue Market Share by Region (2016-2026)
Figure 29. North America Transdermal Drug Delivery Patches Revenue (2016-2026) & (USD Million)
Figure 30. Europe Transdermal Drug Delivery Patches Revenue (2016-2026) & (USD Million)
Figure 31. Asia-Pacific Transdermal Drug Delivery Patches Revenue (2016-2026) & (USD Million)
Figure 32. South America Transdermal Drug Delivery Patches Revenue (2016-2026) & (USD Million)
Figure 33. Middle East & Africa Transdermal Drug Delivery Patches Revenue (2016-2026) & (USD Million)
Figure 34. Global Transdermal Drug Delivery Patches Sales Market Share by Type (2016-2026)
Figure 35. Global Transdermal Drug Delivery Patches Revenue Market Share by Type (2016-2026)
Figure 36. Global Transdermal Drug Delivery Patches Price by Type (2016-2026) & (US$/Unit)
Figure 37. Global Transdermal Drug Delivery Patches Sales Market Share by Application (2016-2026)
Figure 38. Global Transdermal Drug Delivery Patches Revenue Market Share by Application (2016-2026)
Figure 39. Global Transdermal Drug Delivery Patches Price by Application (2016-2026) & (US$/Unit)
Figure 40. North America Transdermal Drug Delivery Patches Sales Market Share by Type (2016-2026)
Figure 41. North America Transdermal Drug Delivery Patches Sales Market Share by Application (2016-2026)
Figure 42. North America Transdermal Drug Delivery Patches Sales Market Share by Country (2016-2026)
Figure 43. North America Transdermal Drug Delivery Patches Revenue Market Share by Country (2016-2026)
Figure 44. United States Transdermal Drug Delivery Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Transdermal Drug Delivery Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Transdermal Drug Delivery Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Transdermal Drug Delivery Patches Sales Market Share by Type (2016-2026)
Figure 48. Europe Transdermal Drug Delivery Patches Sales Market Share by Application (2016-2026)
Figure 49. Europe Transdermal Drug Delivery Patches Sales Market Share by Country (2016-2026)
Figure 50. Europe Transdermal Drug Delivery Patches Revenue Market Share by Country (2016-2026)
Figure 51. Germany Transdermal Drug Delivery Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Transdermal Drug Delivery Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Transdermal Drug Delivery Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Transdermal Drug Delivery Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Transdermal Drug Delivery Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Transdermal Drug Delivery Patches Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Transdermal Drug Delivery Patches Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Transdermal Drug Delivery Patches Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Transdermal Drug Delivery Patches Revenue Market Share by Region (2016-2026)
Figure 60. China Transdermal Drug Delivery Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Transdermal Drug Delivery Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Korea Transdermal Drug Delivery Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Transdermal Drug Delivery Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Transdermal Drug Delivery Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Transdermal Drug Delivery Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Transdermal Drug Delivery Patches Sales Market Share by Type (2016-2026)
Figure 67. South America Transdermal Drug Delivery Patches Sales Market Share by Application (2016-2026)
Figure 68. South America Transdermal Drug Delivery Patches Sales Market Share by Country (2016-2026)
Figure 69. South America Transdermal Drug Delivery Patches Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Transdermal Drug Delivery Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Transdermal Drug Delivery Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East & Africa Transdermal Drug Delivery Patches Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Transdermal Drug Delivery Patches Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa Transdermal Drug Delivery Patches Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Transdermal Drug Delivery Patches Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Transdermal Drug Delivery Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Egypt Transdermal Drug Delivery Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Transdermal Drug Delivery Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. South Africa Transdermal Drug Delivery Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source